SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

    August 24, 2024
    ConferencesSABCS2023
    ConferencesSABCS2023
    Share This:

    Key Points

    NSABP B-51 – Loco-regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node Negative After Neoadjuvant Chemotherapy
    IDEA Update – Five-year Outcomes of the IDEA trial of Endocrine Therapy Without Radiotherapy After Breast-Conserving Surgery for Postmenopausal Patients Aged 50-69 With Genomically-Selected Favorable Stage I Breast Cancer
    ICARO – Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated with Axillary Dissection or Nodal Radiation
    Keynote-522 Update – Event Free Survival with neoadjuvant and adjuvant pembrolizumab in TNBC
    Dr. Eleonora Teplinsky
    Profile

    Dr. Eleonora Teplinsky covering the San Antonio Breast Cancer Symposium 2023

    In discussion with Dr. Eleonora Teplinsky covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Teplinsky

     

    Tags:

    Related Posts

    ConferencesWCLC2025ArticlesSeptember 18, 2025
    WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos
    ConferencesASCO2025July 31, 2025
    Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer